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Caspase-3Abstract The current study was aimed to investigate the role of 5,7-dimethoxycoumarin in the pre-
vention of chronic mild stress induced depression in rats. The chronic mild stress rat model was pre-
pared using the known protocols. The results from open-field test showed that rats in the chronic
mild stress group scored very low in terms of crossings and rearings than those of the normal rats.
However, pre-treatment of the rats with 10 mg/kg doses of 5,7-dimethoxycoumarin prevented
decline in the locomotor activity by chronic mild stress. The level of monoamine oxidase-A in
the chronic mild stress rat hippocampus was markedly higher. Chronic mild stress induced increase
in the monoamine oxidase-A level was inhibited by pre-treatment with 10 mg/kg doses of 5,7-
dimethoxycoumarin in the rats. Chronic mild stress caused a marked increase in the level of
caspase-3 mRNA and proteins in rat hippocampus tissues. The increased level of caspase-3 mRNA
and protein level was inhibited by treatment of rats with 5,7-dimethoxycoumarin (10 mg/kg). 5,7-
Dimethoxycoumarin administration into the rats caused a marked increase in the levels of heat
shock protein-70 mRNA and protein. The levels of heat shock protein-70 were markedly lower bothHeping
e expres-
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sion of heat shock protein-70 and inhibition oin normal and chronic mild stress groups of rats compared to the 5,7-dimethoxycoumarin treated
groups. Thus 5,7-dimethoxycoumarin prevented the chronic mild stress induced depression in rats
through an increase in the expression of heat shock protein-70 and inhibition of monoamine
oxidase-A levels.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Depression is characterized by constant alteration in mood,
negative thoughts, lack of interest in commonly encountered
activities, loss of hope and attempts of suicide (Kessler et al.,
2003). Several studies have been performed over past few dec-
ades but the mechanism behind depression pathogenesis is not
understood fully yet. Currently the medicines used for treat-
ment of depression are any compound which exhibit antide-
pressant properties (Nemeroff, 2007). The use of common
antidepressant compounds causes loss of sleep, loss of mem-
ory, addiction and affects reproductive system (Rosen and
Marin, 2003). Therefore, discovery of new and effective
chemotherapeutic agents free from harmful effect for depres-
sion is needed.
Coumarins, are obtained during the phytochemical investi-
gation of several classes of plants distributed throughout the
world (Egan et al., 1990). Biological evaluation led to identifi-
cation of a broad spectrum of activities of coumarins, includ-
ing anti-oxidant and anti-cancer properties (Maucher et al.,
1993; Sharma et al., 1994; Egan et al., 1997; Hayes et al.,
1998). The modified coumarin analogs as well as their parent
compounds have reached clinical trial stage against several
types of tumors (Lake, 1999). 5,7-Dimethoxycoumarin is
isolated from the species of vegetables Citrus limon L. and
Carica papaya L. (Salvatore et al., 2004; Canini et al., 2007).
5,7-Dimethoxycoumarin has been shown to inhibit the rate
of proliferation of B16 and A375 melanoma cells (Alesiani
et al., 2008). The 5,7-dimethoxycoumarin mediated inhibition
of cell proliferation has been shown to involve cell cycle arrest
in G0/G1 phase. 5,7-Dimethoxycoumarin treatment inhibits
the activation of mitogen-activated protein kinase extracellular
signal-related kinase 1/2 (MAPK Erk 1/2) present at a higher
level in the carcinoma tissues (Fang and Richardson, 2005).
The current study was aimed to investigate the role of
5,7-dimethoxycoumarin in the prevention of chronic mild
stress induced depression in rats. The results demonstrated
that 5,7-dimethoxycoumarin prevented the chronic mild stress
induced depression through an increase in the expression of
heat shock protein-70 and inhibition of monoamine oxidase-
A levels.
2. Materials and methods
2.1. Reagents
5,7-Dimethoxycoumarin was obtained from Sigma–Aldrich
(St. Louis, MO, USA). All the required antibodies were pur-
chased from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA, USA). The enhanced chemiluminescence (ECL) western
blotting kit was supplied by Thermo Scientific (Waltham,
MA, USA).ang, H. 5,7-Dimethoxycoumarin preve
f monoamine oxidase-A levels. Saudi Jo2.2. Animals and approval
Twenty healthy male adult Sprague–Dawley rats (around190 g
in weight) were obtained from The Experimental Animal Cen-
ter of Wenzhou Medical College, Wenzhou, China. Approval
for the present study was obtained from the ethics committee
of the Medical University of Wenzhou (Wenzhou, Zhejiang,
China). All the experimental protocols involving animals were
performed according to the guidelines of the Chinese laws for
animal protection. One week before the start of experiment
animals were acclimatized to the laboratory atmosphere. The
animals were housed under 12 h dark and light cycles with easy
access to water and food.
2.3. Preparation of chronic mild stress animal model
For inducing chronic mild stress, the animals were subjected to
sequence of events mentioned below: deprivation of food and
water for 24 h, movement were restrained for half minute in
iron cages, the cages were rotated for 10 h, encounter of the
rats with new rats for 24 h and day and night durations were
altered. The sequence of events was altered each time starting
with new step. The rats subjected to stress were assigned into
three groups of 5 each: stress group, stress group treated with
5 mg/kg and stress group treated with 10 mg/kg doses of 5,7-
dimethoxycoumarin. Rats in the treatment groups were
intraperitoneally injected with 5 and 10 mg/kg doses of 5,7-
dimethoxycoumarin before subjecting to chronic mild stress.
The animals in normal control and stress groups were given
normal saline.
2.4. Open field test
A box with the dimensions of 100  100  50 cm was used for
determination of locomotory activity of rats. Into the central
square of the box bearing 25 squares, animals were put and
its movements were recorded over a period of 10 min. The
number of times animal crossed was calculated and the results
were compared among the groups.
2.5. Immuno histochemical examination
After completion of the test animals were anesthetized and sac-
rificed to extract entire brain which was dissected on ice into
right and left halves. Right hippocampus half of the brain
was frozen and stored at 80 C under liquid nitrogen atmo-
sphere for analysis using reverse transcription polymerase
chain reaction (RT-PCR). Second hippocampus half was trea-
ted with 4% paraformaldehyde at 4 C for a period of 24 h.
After the treatment, samples were embedded in paraffin and
subsequently sliced into 2-lm thin sections. The sections were
deparaffined, treated with H2O2, and then washed with PBS.nts chronic mild stress induced depression in rats through increase in the expres-
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anti-mouse Hsp70 for 24 h and subsequently with horseradish
peroxidase conjugated secondary antibody for 1 h. The sec-
tions were then treated with a solution of DAB followed by
staining with hematoxylin.
2.6. Reverse transcription–polymerase chain reaction
(RT–PCR)
After completion of the test animals were anesthetized and sac-
rificed to extract entire brain which was dissected on ice into
right and left halves. Right hippocampus half of the brain was
frozen and stored at 80 C under liquid nitrogen atmosphere
for analysis using reverse transcription–polymerase chain reac-
tion (RT–PCR). TRIzol reagent (Tiangen Biotech, Co., Ltd.,
Beijing, China) was used for the isolation of total RNA sample
from the rat hippocampus according to manual protocol. The
RNA samples were reverse transcribed into cDNA and then
subjected to PCR amplification. Separation of the PCR prod-
ucts was performed by electrophoresis using 2% agarose gel.
For visualization and quantification of RNA, ethidium bro-
mide and ImageJ software were used, respectively.
2.7. Western blot analysis
The extracted hippocampus samples were treated with RIPA
buffer containing 1% PMSF on ice for lysis. TRIzol reagent
(Tiangen Biotech, Co., Ltd., Beijing, China) was used for the
isolation of total RNA sample from the rat hippocampus
according to manual protocol. Homogenization of the brain
samples was performed by centrifugation at 1000g for
15 min. The supernatant obtained was centrifuged at
12,000g for a period of 20 min. Following determination of
the protein concentration, the isolated proteins were separated
on 10% sodium dodecyl sulfate–polyacrylamide gels and subse-
quently put onto PVDFmembranes (Millipore Corp., Bedford,
MA, USA). The membrane incubation was performed at 4 C
for overnight with primary antibodies against caspase-3, MAO-
A and Hsp70 using b-actin as internal control. The membrane
washing was performed with PBS before 1 h incubation with
HRP-conjugated secondary antibodies (Rockland, Gil-
bertsville, PA, USA). The protein bands were analyzed using
the system (Odyssey; LI-COR, Inc., Lincoln, NE, USA).
2.8. Statistical analysis
The presented data are mean ± SEM. Comparison of the data
among groups was performed using a one-way ANOVA and
then by the least significant difference (LSD) or Student–New-
man–Keuls (SNK) post hoc tests for multiple pair-wise com-
parisons. SPSS 13.0 software (SPSS, Inc., Chicago, IL, USA)
was used for the statistical tests and P-values <0.05 were
taken to indicate statistically significant differences.
3. Results
3.1. Locomotor activity of 5,7-dimethoxycoumarin
5,7-Dimethoxycoumarin prevents the chronic mild stress
induced damage to locomotor activity in rats. The results fromPlease cite this article in press as: Yang, W., Wang, H. 5,7-Dimethoxycoumarin preve
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group scored very low in terms of crossings and rearings than
those of the normal rats (Fig. 1). However, the rats treated
with 10 mg/kg doses of 5,7-dimethoxycoumarin showed no
marked change in the locomotor activity after chronic mild
stress relative to normal group. Treatment with 5 mg/kg doses
of 5,7-dimethoxycoumarin could not completely prevent the
chronic mild stress induced damage to the locomotor activity.
3.2. 5,7-Dimethoxycoumarin inhibits chronic mild stress induced
increase in level of monoamine oxidase-A
Analysis of the level of monoamine oxidase-A in the hip-
pocampus showed a markedly higher level in chronic mild
stress group than those of normal rats. In the rats treated with
10 mg/kg doses of 5,7-dimethoxycoumarin prior to chronic
mild stress no change was observed in monoamine oxidase-A
level compared to the normal group (Fig. 2).
3.3. 5,7-Dimethoxycoumarin inhibits the chronic mild stress
induced increase in level ofcaspase-3
Chronic mild stress caused a marked increase in the level of
caspase-3 mRNA and proteins in rat hippocampus tissues
compared to the normal group (Fig. 3). However, the
caspase-3 mRNA and protein level in 5,7-dimethoxy-
coumarin (10 mg/kg) treated rat hippocampus was marked
lower compared to the chronic mild stress rats. The levels of
caspase-3 mRNA and proteins were almost similar in the hip-
pocampus of 5,7-dimethoxycoumarin (10 mg/kg) treated and
normal rats (Fig. 3).
3.4. 5,7-Dimethoxycoumarin increases the level of heat shock
protein-70 in the rat hippocampus
Chronic mild stress group of rats showed a markedly lower
level of heat shock protein-70 mRNA and protein compared
to the rats treated with 10 mg/kg doses of 5,7-dimethoxy-
coumarin (Figs. 4 and 5). The levels of heat shock protein-70
were markedly lower both in normal and chronic mild stress
groups of rats compared to the 5,7-dimethoxycoumarin treated
groups.
4. Discussion
In the current study protective effect of 5,7-dimethoxy-
coumarin on chronic mild stress induced depression in rats
was investigated. Depression is caused by reduction in the
expression level of neurotransmitters which play a vital role
in transmission of neuronal signals (Manji et al., 2001;
Mathew et al., 2008). Studies have shown that the level of most
common neurotransmitter, monoamine oxidase is markedly
reduced during depression (Elhwuegi, 2004; Meyer et al.,
2006). Catabolism of monoamines is a vital process for trans-
mission of neuronal signals and its up-regulation leads to onset
of depression (Du et al., 2002). Current study revealed that rats
in the chronic mild stress group showed poor locomotory
activity than those of the normal rats. The rats treated with
10 mg/kg doses of 5,7-dimethoxycoumarin prior to chronic
mild stress showed no marked change in the locomotor activ-nts chronic mild stress induced depression in rats through increase in the expres-
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Figure 1 5,7-Dimethoxycoumarin prevents chronic mild stress induced damage to locomotor activity in rats. The rats were treated with
5 and 10 mg/kg doses of 5,7-dimethoxycoumarin and then subjected to chronic mild stress. Following chronic mild stress induction
number of crossing (A) and rearings (B) in the box by each rat was calculated over a 10 min period. The expressed values are mean ± SD.
*p< 0.02 vs control and **p< 0.02 vs stress group.
Figure 2 5,7-Dimethoxycoumarin inhibits chronic mild stress induced increase in monoamine oxidase-A. Rats after pre-treatment with
5,7-dimethoxycoumarin were subjected to chronic mild stress and then sacrificed to extract the brain samples. The brain samples were
subjected to RT-PCR and western blot assay for analysis of monoamine oxidase-A expression. *p< 0.02 vs control, #p< 0.02 vs stress
group.
Figure 3 5,7-Dimethoxycoumarin inhibits the chronic mild stress induced increase in level of caspase-3. Rats after pre-treatment with
5,7-dimethoxycoumarin were subjected to chronic mild stress and then sacrificed to extract the brain samples. The brain samples were
subjected to RT-PCR and western blot assay for analysis of caspase-3 expression. *p< 0.02 vs control, #p< 0.02 vs stress group.
4 W. Yang, H. Wangity. In the current study, pre-treatment of rats with 10 mg/kg
doses of 5,7-dimethoxycoumarin prevented the chronic mild
stress induced increase in monoamine oxidase-A level. The
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pus. Studies have shown that antidepressants also interfere
with the expression level of heat shock protein-70 which plays
an important role in cell protection (Tanito et al., 2005). Ournts chronic mild stress induced depression in rats through increase in the expres-
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Figure 4 5,7-Dimethoxycoumarin increases the level of heat shock protein-70 in the rat hippocampus. Rats after pre-treatment with 5,7-
dimethoxycoumarin were subjected to chronic mild stress and then sacrificed to extract the brain samples. The brain samples were
subjected to RT-PCR and western blot assay for analysis of heat shock protein-70 expression. *p< 0.02 vs control, #p< 0.02 vs stress
group.
Figure 5 Effect of 5,7-dimethoxycoumarin on heat shock protein-70 expression using immunohistochemical staining. Rats after pre-
treatment with 5,7-dimethoxycoumarin were subjected to chronic mild stress and then sacrificed to extract the brain samples. The brain
samples were subjected to RT-PCR and western blot assay for analysis of heat shock protein-70 expression.
5,7-Dimethoxycoumarin prevents chronic mild stress induced depression in rats 5results from current study showed a marked increase in the
level of heat shock protein-70 in rats on treatment with 5,7-
dimethoxycoumarin. The heat shock protein-70 level in
chronic mild stress and normal control rats was found to be
markedly lower.
It has been observed in patients with depression that neu-
rons and glial cells have undergone apoptosis (Lenze et al.,
1999; Eastwood and Harrison, 2001; Nolan et al., 1999). The
density of neurons in hippocampus of patients with depression
has been found to be low (Gould and Tanapat, 1999; McEwen
2007). The cell apoptosis is induced by an increase in the
expression level of caspase-3 (Woo et al., 1998). Our results
showed a markedly higher level of caspase-3 in chronic mild
stress induced rats. In the rats pre-treated with 5,7-
dimethoxycoumarin the chronic mild stress induced increase
in the level of caspase-3 was prevented. Thus, 5,7-
dimethoxycoumarin treatment prevents induction of apoptosis
in rat hippocampal neurons by inhibiting expression of
caspase-3.
5. Conclusion
In summary, 5 mg/kg doses of 5,7-dimethoxycoumarin pre-
vents chronic mild stress induced depression in rats through
reduction in the expression of monoamine oxidase-A and
increase in the level of heat shock protein-70 as well as inhibi-
tion of apoptosis induction. Thus, 5,7-dimethoxycoumarin has
a scope to be evaluated further for the treatment of depression.
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